110 related articles for article (PubMed ID: 22063920)
1. A novel fused 1,2,4-triazine aryl derivative as antioxidant and nonselective antagonist of adenosine A(2A) receptors in ethanol-activated liver stellate cells.
Szuster-Ciesielska A; Sztanke K; Kandefer-Szerszeń M
Chem Biol Interact; 2012 Jan; 195(1):18-24. PubMed ID: 22063920
[TBL] [Abstract][Full Text] [Related]
2. Butein inhibits ethanol-induced activation of liver stellate cells through TGF-β, NFκB, p38, and JNK signaling pathways and inhibition of oxidative stress.
Szuster-Ciesielska A; Mizerska-Dudka M; Daniluk J; Kandefer-Szerszeń M
J Gastroenterol; 2013 Feb; 48(2):222-37. PubMed ID: 22722906
[TBL] [Abstract][Full Text] [Related]
3. Zinc supplementation attenuates ethanol- and acetaldehyde-induced liver stellate cell activation by inhibiting reactive oxygen species (ROS) production and by influencing intracellular signaling.
Szuster-Ciesielska A; Plewka K; Daniluk J; Kandefer-Szerszeń M
Biochem Pharmacol; 2009 Aug; 78(3):301-14. PubMed ID: 19376089
[TBL] [Abstract][Full Text] [Related]
4. Betulin and betulinic acid attenuate ethanol-induced liver stellate cell activation by inhibiting reactive oxygen species (ROS), cytokine (TNF-α, TGF-β) production and by influencing intracellular signaling.
Szuster-Ciesielska A; Plewka K; Daniluk J; Kandefer-Szerszeń M
Toxicology; 2011 Feb; 280(3):152-63. PubMed ID: 21172400
[TBL] [Abstract][Full Text] [Related]
5. NF-κB enhances hypoxia-driven T-cell immunosuppression via upregulation of adenosine A(2A) receptors.
Bruzzese L; Fromonot J; By Y; Durand-Gorde JM; Condo J; Kipson N; Guieu R; Fenouillet E; Ruf J
Cell Signal; 2014 May; 26(5):1060-7. PubMed ID: 24486403
[TBL] [Abstract][Full Text] [Related]
6. Adenosine A(2A) Receptors as novel upstream regulators of BDNF-mediated attenuation of hippocampal Long-Term Depression (LTD).
Rodrigues TM; Jerónimo-Santos A; Sebastião AM; Diógenes MJ
Neuropharmacology; 2014 Apr; 79():389-98. PubMed ID: 24361450
[TBL] [Abstract][Full Text] [Related]
7. Adenosine A(2A) receptors play a role in the pathogenesis of hepatic cirrhosis.
Chan ES; Montesinos MC; Fernandez P; Desai A; Delano DL; Yee H; Reiss AB; Pillinger MH; Chen JF; Schwarzschild MA; Friedman SL; Cronstein BN
Br J Pharmacol; 2006 Aug; 148(8):1144-55. PubMed ID: 16783407
[TBL] [Abstract][Full Text] [Related]
8. Toll-like receptors, NF-κB, and IL-27 mediate adenosine A2A receptor signaling in BTBR T
Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Al-Ayadhi LY; Attia SM
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):184-191. PubMed ID: 28668513
[TBL] [Abstract][Full Text] [Related]
9. Adenosine A2A receptor signaling affects IL-21/IL-22 cytokines and GATA3/T-bet transcription factor expression in CD4
Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Almutairi MM; Attia SM
J Neuroimmunol; 2017 Oct; 311():59-67. PubMed ID: 28807491
[TBL] [Abstract][Full Text] [Related]
10. Adenosine A2A receptor activation is determinant for BDNF actions upon GABA and glutamate release from rat hippocampal synaptosomes.
Vaz SH; Lérias SR; Parreira S; Diógenes MJ; Sebastião AM
Purinergic Signal; 2015 Dec; 11(4):607-12. PubMed ID: 26452489
[TBL] [Abstract][Full Text] [Related]
11. Involvement of cAMP-PKA pathway in adenosine A1 and A2A receptor-mediated regulation of acetaldehyde-induced activation of HSCs.
Yang Y; Wang H; Lv X; Wang Q; Zhao H; Yang F; Yang Y; Li J
Biochimie; 2015 Aug; 115():59-70. PubMed ID: 25956975
[TBL] [Abstract][Full Text] [Related]
12. Adenosine A(2A) receptor activation prevents progressive kidney fibrosis in a model of immune-associated chronic inflammation.
Garcia GE; Truong LD; Chen JF; Johnson RJ; Feng L
Kidney Int; 2011 Aug; 80(4):378-88. PubMed ID: 21508927
[TBL] [Abstract][Full Text] [Related]
13. Adenosine A₂A receptors inhibit delayed rectifier potassium currents and cell differentiation in primary purified oligodendrocyte cultures.
Coppi E; Cellai L; Maraula G; Pugliese AM; Pedata F
Neuropharmacology; 2013 Oct; 73():301-10. PubMed ID: 23770463
[TBL] [Abstract][Full Text] [Related]
14. Regression of liver fibrosis by taurine in rats fed alcohol: effects on collagen accumulation, selected cytokines and stellate cell activation.
Devi SL; Viswanathan P; Anuradha CV
Eur J Pharmacol; 2010 Nov; 647(1-3):161-70. PubMed ID: 20813107
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the potent and highly selective A2A receptor antagonists preladenant and SCH 412348 [7-[2-[4-2,4-difluorophenyl]-1-piperazinyl]ethyl]-2-(2-furanyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine] in rodent models of movement disorders and depression.
Hodgson RA; Bertorelli R; Varty GB; Lachowicz JE; Forlani A; Fredduzzi S; Cohen-Williams ME; Higgins GA; Impagnatiello F; Nicolussi E; Parra LE; Foster C; Zhai Y; Neustadt BR; Stamford AW; Parker EM; Reggiani A; Hunter JC
J Pharmacol Exp Ther; 2009 Jul; 330(1):294-303. PubMed ID: 19332567
[TBL] [Abstract][Full Text] [Related]
16. Dual blockade of the A1 and A2A adenosine receptor prevents amyloid beta toxicity in neuroblastoma cells exposed to aluminum chloride.
Giunta S; Andriolo V; Castorina A
Int J Biochem Cell Biol; 2014 Sep; 54():122-36. PubMed ID: 25058312
[TBL] [Abstract][Full Text] [Related]
17. Adenosine A2A receptor contributes to ischemic brain damage in newborn piglet.
Yang ZJ; Wang B; Kwansa H; Heitmiller KD; Hong G; Carter EL; Jamrogowicz JL; Larson AC; Martin LJ; Koehler RC
J Cereb Blood Flow Metab; 2013 Oct; 33(10):1612-20. PubMed ID: 23860373
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotection afforded by adenosine A2A receptor blockade is modulated by corticotrophin-releasing factor (CRF) in glutamate injured cortical neurons.
Valadas JS; Batalha VL; Ferreira DG; Gomes R; Coelho JE; Sebastião AM; Diógenes MJ; Lopes LV
J Neurochem; 2012 Dec; 123(6):1030-40. PubMed ID: 23057965
[TBL] [Abstract][Full Text] [Related]
19. Selective A
Bortolatto CF; Reis AS; Pinz MP; Voss GT; Oliveira RL; Vogt AG; Roman S; Jesse CR; Luchese C; Wilhelm EA
Metab Brain Dis; 2017 Dec; 32(6):1919-1927. PubMed ID: 28795281
[TBL] [Abstract][Full Text] [Related]
20. Effects of the selective adenosine A2A receptor antagonist, SCH 412348, on the parkinsonian phenotype of MitoPark mice.
Smith KM; Browne SE; Jayaraman S; Bleickardt CJ; Hodge LM; Lis E; Yao L; Rittle SL; Innocent N; Mullins DE; Boykow G; Reynolds IJ; Hill D; Parker EM; Hodgson RA
Eur J Pharmacol; 2014 Apr; 728():31-8. PubMed ID: 24486705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
